This section provides various financial ratios derived from the company's financial statements to help assess its performance and financial health. Below are Current Ratio, Quick Ratio, Cash Ratio, Net Profit Margin for APRE as of 2025-12-31.
| Financial Ratios | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net Profit Margin | -73,743.182 | -160,905.141 | -2,743.649 | -2,420.253 |
| Cash Ratio | 528.128 | 511.656 | 521.904 | - |
| Quick Ratio | 562.924 | 520.083 | 534.374 | - |
| Current Ratio | 562.924 | 520.083 | 534.374 | - |
Aprea Therapeutics, Inc. (APRE)
Aprea Therapeutics, Inc. (APRE)